UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                  Form 10-QSB/A


(Mark one)

[X]  Quarterly  Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the quarterly period ended June 30, 2006

[_]  Transition Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________


Commission File Number: 0-32379


                            American Ammunition, Inc.
--------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)


         Nevada                                              91-2021594
------------------------                             --------------------------
(State of incorporation)                               (IRS Employer ID Number)


                      3545 NW 71st Street, Miami, FL 33147
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (305) 835-7400
--------------------------------------------------------------------------------
                           (Issuer's telephone number)




Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. YES [X] NO [_]


Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act): YES [_] NO [X]


State the number of shares outstanding of each of the issuer's classes of common
equity as of the  latest  practicable  date:  As of  September  17,  2007:,  the
Transfer Agent's records indicate that there are 28,372,922 shares  outstanding.
Of  these  shares,  a total of  21,803,335  shares  were  subject  to an  escrow
agreement referenced in later filings.


Transitional Small Business Disclosure Format (check one): YES [_] NO [X]







                            American Ammunition, Inc.
               Form 10-QSB/A for the Quarter ended June 30, 2006

                                Table of Contents


                                                                           Page

                         PART I - FINANCIAL INFORMATION

  ITEM 1 - Financial Statements                                              3

  ITEM 2 - Management's Discussion and Analysis or Plan of Operation        25

  ITEM 3 - Controls and Procedures                                          30

                           PART II - OTHER INFORMATION

  ITEM 1 - Legal Proceedings                                                30

  ITEM 2 - Unregistered Sales of Equity Securities and Use of Proceeds      30

  ITEM 3 - Defaults Upon Senior Securities                                  33

  ITEM 4 - Submission of Matters to a Vote of Security Holders              33

  ITEM 5 - Other Information                                                33

  ITEM 6 - Exhibits                                                         33


SIGNATURES                                                                  33









                         PART I - FINANCIAL INFORMATION

ITEM 1 - Financial Statements

The June 30, 2006 and 2005  financial  statements  have been restated to account
for the  derivative  liability  that was incurred in connection  with the common
stock conversion features and the warrants issued with certain notes payable.



                   American Ammunition, Inc. and Subsidiaries
                           Consolidated Balance Sheets
                                  June 30, 2006
                                   (Unaudited)
                                                                                  (Restated)
                                                                                June 30, 2006
                                                                                -------------
                                                                             
                                     ASSETS
Current Assets
   Cash on hand and in bank                                                     $     250,413
   Accounts receivable - trade,
         net of allowance for doubtful accounts of $10,000                            241,954
   Inventory                                                                          426,676
   Prepaid interest                                                                   226,169
   Prepaid expenses                                                                    55,324
                                                                                -------------
     Total Current Assets                                                           1,200,536
                                                                                -------------
Property and Equipment - at cost                                                            -
                                                                                -------------
Other Assets                                                                          294,424
                                                                                -------------
TOTAL ASSETS                                                                    $   1,494,960
                                                                                =============
                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
   Notes payable to stockholders                                                $   1,075,000
   Convertible debenture                                                              226,365
   Working capital advance                                                            200,000
   Customer deposits                                                                  188,020
   Accounts payable - trade                                                           804,847
   Accrued salaries and wages                                                         337,648
   Accrued interest payable                                                            30,162
   Accrued dividends payable                                                           71,221
   Derivative liability from note conversion features                               3,229,770
                                                                                -------------
     Total Current Liabilities                                                      6,163,033
                                                                                -------------
Commitments and Contingencies

Stockholders' Equity (Deficit)
   Preferred stock - $0.001 par value 20,000,000 shares authorized.
     2,072,902 shares and outstanding                                                   2,072
   Common stock - $0.001 par value.  300,000,000 shares authorized.
     5,122,931 shares issued and outstanding                                            5,123
   Additional paid-in capital                                                      26,039,482
   Accumulated other comprehensive loss                                            (2,652,018)
   Accumulated deficit                                                            (27,887,732)
                                                                                -------------
                                                                                   (4,493,073)
   Stock subscription receivable                                                     (175,000)
                                                                                -------------
     Total Stockholders' Equity (Deficit)                                          (4,668,073)
                                                                                -------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                      $   1,494,960
                                                                                =============



                   The accompanying notes are an integral part
                  of these consolidated financial statements.

                                        3





                   American Ammunition, Inc. and Subsidiaries
      Consolidated Statements of Operations and Comprehensive Income (Loss)
                Six and Three months ended June 30, 2006 and 2005
                                   (Unaudited)

                                              (Restated)        (Restated)        (Restated)        (Restated)
                                              Six months        Six months       Three months   Three months
                                                 ended             ended            ended          ended
                                             June 30, 2006      June 30, 2005   June 30, 2006   June 30, 2005
                                             -------------      -------------   -------------   -------------
                                                                                    
Revenues                                     $   1,379,497      $   1,855,010   $     669,386   $     684,693
                                             -------------      -------------   -------------   -------------
Cost of Sales
   Materials, direct Labor
      and other direct costs                     2,012,170          2,502,842         665,089       1,153,511
   Depreciation                                     31,024            382,311               -         195,062
                                             -------------      -------------   -------------   -------------
      Total Cost of Sales                        2,043,194          2,885,153         665,089       1,348,573
                                             -------------      -------------   -------------   -------------
Gross Profit                                      (663,697)        (1,030,143)          4,297        (676,300)
                                             -------------      -------------   -------------   -------------
Operating Expenses
   Research and development expenses                     -              1,611               -           6,474
   Selling and marketing expenses                   74,075            111,752          18,258         130,875
   Other operating expenses                        852,390            832,023         477,482         339,425
   Interest expense                                302,789             14,694         152,460           5,070
   Depreciation and amortization                    27,569             30,203          13,784           1,893
                                             -------------      -------------   -------------   -------------
      Total Operating Expenses                   1,256,823            990,283         661,984         483,737
                                             -------------      -------------   -------------   -------------
Loss from Operations                            (1,920,520)        (2,020,626)       (657,687)     (1,160,037)

Other Income (Expense)
   Interest and other income                       189,492              6,232         147,935             167
                                             -------------      -------------   -------------   -------------
Loss before Income Taxes                        (1,731,028)        (2,014,394)       (509,752)     (1,159,870)

Provision for Income Taxes                               -                  -               -               -
                                             -------------      -------------   -------------   -------------
Net Loss                                        (1,731,028)        (2,014,394)       (509,752)     (1,159,870)

Other Comprehensive Income (Loss)
   Change in derivative related
      to note conversion                        (2,694,571)               783          54,379             783
                                             -------------      -------------   -------------   -------------
Comprehensive Loss                           $  (4,425,599)     $  (2,013,611)  $    (455,373)  $  (1,159,087)
                                             =============      =============   =============   =============

Preferred Stock Dividends                          (43,492)           (27,221)        (31,440)        (13,610)
                                             -------------      -------------   -------------   -------------
Net Loss available to
   Common Shareholders                       $  (1,774,520)     $  (2,041,615)  $    (541,192)  $  (1,172,697)
                                             =============      =============   =============   =============
Loss per weighted-average share of
   common stock outstanding,
   computed on net loss -
   basic and fully diluted                   $       (0.39)     $       (0.59)  $       (0.11)  $       (0.33)
                                             =============      =============   =============   =============
Weighted-average number of
   common shares outstanding                     4,537,640          3,472,930       4,797,286       3,557,402
                                             =============      =============   =============   =============



                   The accompanying notes are an integral part
                  of these consolidated financial statements.

                                        4





                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                     Six months ended June 30, 2006 and 2005
                                   (Unaudited)

                                                                                 (Restated)        (Restated)
                                                                                 Six months      Six months
                                                                                    ended           ended
                                                                                June 30, 2006   June 30, 2005
                                                                                -------------   -------------
                                                                                          
Cash flows from operating activities
   Net loss for the period                                                      $  (1,731,028)  $  (2,014,394)
   Adjustments to reconcile net loss to net cash provided
   by operating activities
       Depreciation and amortization                                                  311,731         417,077
       Bad debt expense                                                                14,153               -
       Operating expenses paid with common stock                                       20,186               -
   Consulting expense related to common stock sales at less than "fair value"         139,373         200,502
       (Increase) Decrease in
         Accounts receivable                                                          315,320         446,589
         Inventory                                                                    133,414         363,808
         Prepaid expenses, deposits and other                                           1,465           2,464
Increase (Decrease) in
         Accounts payable - trade                                                     (41,770)       (250,630)
         Other accrued expenses                                                        91,719          37,522
         Accrued interest payable                                                      40,494               -
         Customer deposits                                                            (44,670)              -
                                                                                -------------   -------------
Net cash used in operating activities                                                (749,613)       (797,062)
                                                                                -------------   -------------
Cash flows from investing activities
   Purchase of property and equipment                                                 (31,024)        (98,400)
                                                                                -------------   -------------
Net cash used in investing activities                                                 (31,024)        (98,400)
                                                                                -------------   -------------
Cash flows from financing activities
   Cash advanced on loans from stockholders                                           100,000         150,000
   Cash received on working capital advance                                            50,000               -
   Cash received from the sale of preferred stock                                     500,000               -
   Cash received from sale of common stock                                                  -         436,606
   Cash paid to acquire capital                                                       (50,000)        (10,000)
                                                                                -------------   -------------
Net cash provided by financing activities                                             600,000         576,606
                                                                                -------------   -------------
Increase (Decrease) in Cash                                                          (180,637)       (318,856)
Cash at beginning of year                                                             431,050         805,465
                                                                                -------------   -------------
Cash at end of period                                                           $   250,413       $   486,609
                                                                                =============   =============
Supplemental disclosure of interest and income taxes paid
     Interest paid for the period                                               $       9,157   $      10,131
                                                                                =============   =============
     Income taxes paid for the period                                           $           -   $           -
                                                                                =============   =============
Supplemental disclosure of non-cash investing and financing activities
     Conversion of debt and/or accrued interest payable
       into common stock                                                        $     36,720    $      25,000
                                                                                =============   =============
     Common stock issued in payment for costs of raising capital                $           -   $           -
                                                                                =============   =============
     Common stock issued in payment of accrued dividends
       on Preferred Stock - Series A and Series B                               $           -   $       9,171
                                                                                =============   =============



                   The accompanying notes are an integral part
                  of these consolidated financial statements.

                                        5



                   American Ammunition, Inc. and Subsidiaries
               Notes to Restated Consolidated Financial Statements
                             June 30, 2006 and 2005


Note A - Organization and Description of Business

American Ammunition,  Inc. (AAI or Company) was incorporated on February 1, 2000
in accordance with the Laws of the State of California. The Company functions as
a holding company providing  management  oversight services to it's wholly-owned
operating  subsidiaries;  F&F Equipment,  Inc. and Industrial Plating Enterprise
Co.

F&F Equipment,  Inc.(F&F) was incorporated on October 4, 1983 in accordance with
the Laws of the State of Florida. F&F is engaged in the design,  manufacture and
international  sales of small arms  ammunition.  F&F has  conducted its business
operations under the assumed name of "American Ammunition" since its inception.

Industrial  Plating  Enterprise Co. (IPE),  which was incorporated and commenced
production on June 14, 2002.  IPE is a fully  licensed and approved state of the
art electrochemical  metallization facility for processing the Company's line of
small arms  projectiles as well as other  products and services while  employing
environmentally  sound water conservation and proven waste treatment techniques.
The facility meets or exceeds all current environmental  requirements and enjoys
the "conditionally exempt small quantity generator" status for State and Federal
regulations.  All  activities of IPE since it's inception have been dedicated to
the needs and demands of F&F.

On January 9, 2006,  by written  consent in lieu of  meeting,  a majority of the
Company's  stockholders  approved a  recommendation  by the  Company's  Board of
Directors  to effect a one share for twenty  shares  reverse  stock split of our
common stock,  par value $.001 per share,  with fractional  shares rounded up to
the nearest whole share.  The reverse split became  effective on that date. As a
result of the reverse split,  the total number of issued and outstanding  shares
of the Company's  common stock  decreased  from  92,576,839 to  4,629,381shares,
after giving effect to rounding for fractional shares. The effect of this action
is reflected in the  Company's  financial  statements as of the first day of the
first period presented.


Note B - Preparation of Financial Statements

The  Company and its  subsidiaries  follow the accrual  basis of  accounting  in
accordance with accounting principles generally accepted in the United States of
America and have adopted a year-end of December 31 for all entities.

The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period. Actual results could differ from those estimates.

Management further acknowledges that it is solely responsible for adopting sound
accounting  practices,   establishing  and  maintaining  a  system  of  internal
accounting  control and preventing and detecting  fraud. The Company's system of
internal  accounting  control is designed to assure,  among other items, that 1)
recorded  transactions  are valid; 2) valid  transactions  are recorded;  and 3)
transactions  are  recorded in the proper  period in a timely  manner to produce
financial  statements which present fairly the financial  condition,  results of
operations  and cash  flows of the  Company  for the  respective  periods  being
presented


                                       6




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note B - Preparation of Financial Statements - Continued

During interim periods, the Company follows the accounting policies set forth in
its annual  audited  financial  statements  filed with the U. S.  Securities and
Exchange  Commission  on its  Annual  Report on Form  10-KSB  for the year ended
December 31, 2005.  The  information  presented  within these interim  financial
statements  may not  include all  disclosures  required  by  generally  accepted
accounting  principles  and the  users of  financial  information  provided  for
interim periods should refer to the annual  financial  information and footnotes
when reviewing the interim financial results presented herein.

In the opinion of management,  the accompanying  interim  financial  statements,
prepared in  accordance  with the U. S.  Securities  and  Exchange  Commission's
instructions   for  Form  10-QSB,   are   unaudited  and  contain  all  material
adjustments,  consisting  only of  normal  recurring  adjustments  necessary  to
present fairly the financial condition,  results of operations and cash flows of
the Company for the respective  interim  periods  presented.  The current period
results of operations are not necessarily indicative of results which ultimately
will be reported for the full fiscal year ending December 31, 2006.

For  segment  reporting  purposes,  the Company  operated  in only one  industry
segment during the periods represented in the accompanying  financial statements
and makes all  operating  decisions and  allocates  resources  based on the best
benefit to the Company as a whole.

The  accompanying  consolidated  financial  statements  contain the  accounts of
American Ammunition, Inc. and its wholly-owned subsidiaries, F&F Equipment, Inc.
and Industrial Plating Enterprise Co. All significant intercompany  transactions
have been eliminated.  The consolidated entities are collectively referred to as
"Company".


Note C - Summary of Significant Accounting Policies

1.   Cash and cash equivalents

     For  Statement of Cash Flows  purposes,  the Company  considers all cash on
     hand  and  in  banks,  certificates  of  deposit  and  other  highly-liquid
     investments with maturities of three months or less, when purchased,  to be
     cash and cash equivalents.

     Cash  overdraft  positions may occur from time to time due to the timing of
     making bank deposits and releasing checks, in accordance with the Company's
     cash management policies.

2.   Accounts receivable and Revenue Recognition

     In the normal course of business,  the Company extends  unsecured credit to
     virtually  all of its  customers  which are located  throughout  the United
     States.  Because of the credit risk  involved,  management  has provided an
     allowance for doubtful accounts which reflects its opinion of amounts which
     will   eventually   become   uncollectible.   In  the  event  of   complete
     non-performance, the maximum exposure to the Company is the recorded amount
     of trade  accounts  receivable  shown on the  balance  sheet at the date of
     non-performance.



                                       7




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note C - Summary of Significant Accounting Policies - Continued

2.   Accounts receivable and Revenue Recognition - continued

     The Company ships all product on an FOB-Plant,  "as-is" basis. Accordingly,
     revenue  is  recognized  by the  Company  at the point at which an order is
     shipped at a fixed price,  collection is reasonably assured and the Company
     has no remaining  performance  obligations related to the sale. The Company
     sells all  products  with "no right of  return"  by the  purchaser  for any
     factor other than defects in the product's production.

     In limited situations, the Company may elect to accept product returns from
     customers on a  case-by-case  basis to offset unpaid  accounts  receivable.
     These  situations  are a "last case"  scenario and are  initiated by senior
     management through negotiations with the respective customer.

3.   Inventory

     Inventory  consists of raw  materials,  work-in-process  and finished goods
     related to the production and sale of small arms  ammunition.  Inventory is
     valued at the lower of cost or market using the first-in, first-out method.

4.   Property, plant and equipment

     Property and  equipment are recorded at  historical  cost.  These costs are
     depreciated over the estimated useful lives of the individual  assets using
     the straight-line method, generally three to ten years.

     Gains and losses from  disposition of property and equipment are recognized
as incurred and are included in operations.

     In accordance  with  Statement of Financial  Accounting  Standards No. 144,
     "Accounting  for the  Impairment  or Disposal of  Long-Lived  Assets",  the
     Company  follows the policy of evaluating  all property and equipment as of
     the end of each reporting  quarter.  At December 31, 2005,  pursuant to the
     requirements of this accounting standard, management recorded an impairment
     against  the  future   recoverability  of  these  assets  of  approximately
     $2,777,829.

5.   Income Taxes

     The Company uses the asset and liability  method of  accounting  for income
     taxes.  At June 30, 2006 and 2005,  the deferred tax asset and deferred tax
     liability accounts,  as recorded when material to the financial statements,
     are  entirely the result of temporary  differences.  Temporary  differences
     represent  differences in the recognition of assets and liabilities for tax
     and financial reporting purposes,  primarily  accumulated  depreciation and
     amortization, allowance for doubtful accounts and vacation accruals.

     As of June 30, 2006 and 2005, respectively,  the deferred tax asset related
     to the Company's net operating loss carryforward is fully reserved.  In the
     event that these carryforwards were not fully utilized, these carryforwards
     began to expire in 2005.



                                       8



                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note C - Summary of Significant Accounting Policies - Continued

6.   Earnings (loss) per share

     Basic  earnings  (loss) per share is computed  by  dividing  the net income
     (loss) available to common stockholders by the  weighted-average  number of
     common shares  outstanding  during the respective  period  presented in our
     accompanying financial statements.

     Fully diluted earnings (loss) per share is computed similar to basic income
     (loss) per share  except that the  denominator  is increased to include the
     number of common  stock  equivalents  (primarily  outstanding  options  and
     warrants).

     Common  stock  equivalents  represent  the  dilutive  effect of the assumed
     exercise of the outstanding stock options and warrants,  using the treasury
     stock method, at either the beginning of the respective period presented or
     the date of  issuance,  whichever  is later,  and only if the common  stock
     equivalents  are  considered  dilutive  based upon the Company's net income
     (loss) position at the calculation date.

     As of June 30, 2006 and 2005,  and subsequent  thereto,  the Company had no
     options  outstanding.  The outstanding  warrants and convertible  preferred
     stock and mandatorily  convertible  debentures are anti-dilutive due to the
     Company's net operating loss position.

7.   Advertising costs

     The Company does not conduct any direct  response  advertising  activities.
     For non-direct response advertising, the Company charges the costs of these
     efforts  to  operations  at the  first  time  the  related  advertising  is
     published.

Note D - Correction of an Error

On August 22, 2007,  our  management  concluded  that the  financial  statements
included in our Forms 10-QSB for June and September 2005, the calendar year 2006
and for the period  ending March 31, 2007,  and the Forms 10-KSB for the periods
ending  December  31,  2005  and  December  31,  2006,  all of which  have  been
previously  filed  with  the  Securities  and  Exchange  Commission,  need to be
restated,  due to the  failure  to include  the  beneficial  conversion  feature
discount on unsecured convertible indebtedness.

Management  discovered  such  changes  needed to be made after  consulting  with
Pollard-Kelley  Auditing Services,  our independent registered public accounting
firm  as of  June  26,  2007,  who  have  concurred  with  management  as to the
reexamination of the above mentioned issues.

The Company has entered into certain  notes  payable to  shareholders  and other
affiliated  parties with embedded  conversion  features and warrant issues.  The
appropriate  accounting is governed by EITF 98-5:  "Accounting  for  convertible
securities  with  beneficial  conversion  features  or  contingency   adjustable
conversion"  and  EITF No.  00-27:  "Application  of  issue  No 98-5 to  certain
convertible instruments". Conversion features determined to be beneficial to the
holder are valued at fair value and recorded to additional paid in capital.  The
fair value is determined to be ascribed to the detachable  warrants  issued with



                                       9




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note D - Correction of an Error - Continued

the convertible  debentures  utilizing the  Black-Scholes  method.  Any discount
derived from determining the fair value to the debenture conversion features and
warrants is  amortized  to financing  cost over the life of the  debenture.  The
unamortized  discount, if any, upon the conversion of the debentures is expensed
to financing cost on a pro rata basis.

Debt issues with the variable  conversion features are considered to be embedded
derivatives  and are  accountable in accordance  with FASB 133;  "Accounting for
Derivative  Instruments and Hedging Activities".  The fair value of the embedded
derivative is recorded to derivative liability. This liability is required to be
marked each reporting period. The resulting discount on the debt is amortized to
interest expense over the life of the related debt.

The errors discovered by management relate directly to the accounting for and
recording various conversion features and warrants as follows:



                                                                  Six months       Six months
                                                                     ended            ended
                                                                 June 30, 2006    June 30, 2005
                                                                 --------------   ---------------
                                                                            
Net Loss, as previously reported                                 $   (1,504,860)  $    (2,009,831)

Effect of the correction of an error
(Increase) Decrease in Net Loss by financial statement line item:
     Operating expenses: Interest expense recognized
       from beneficial conversion discount feature on
       notes payable to shareholders and other affiliates              (226,168)           (4,563)
                                                                 --------------   ---------------
   Total effect of changes on Loss from Operations and Net Loss        (226,168)           (4,563)
                                                                 --------------   ---------------

Net Loss, as restated                                            $   (1,731,028)  $    (2,014,394)
                                                                 ==============   ===============

Net loss available to common stockholders,
                         as previously reported                  $   (1,548,352)  $    (2,037,052)

Effect of the correction of an error
   Total effect as shown above                                         (226,168)           (4,563)
                                                                 --------------   ---------------
Net Loss available to common stockholders, as restated           $   (1,774,520)  $    (2,041,615)
                                                                 ==============   ===============

Earnings per share, as previously reported                       $        (0.34)$           (0.59)
Total effect of changes                                                   (0.05)            (0.00)
                                                                 --------------   ---------------
Earnings per share, as restated                                  $        (0.39)  $         (0.59)
                                                                 ==============   ===============








                                       10




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note D - Correction of an Error - Continued

In  light of the  restatements  to the  financial  statements  disclosed  above,
caused,  in part, by a failure in the Company's  internal control over financing
reporting  due to the  limitations  in the  Company's  accounting  resources  to
identify  and  react  in  a  timely  manner  to   non-routine,   complex  and/or
transactions  originated by other parties on the  Company's  behalf,  as well as
gaining an adequate  understanding  of the disclosure  requirements  relating to
these types of transactions,  we feel that the existing  controls and procedures
were and remain  effective.  Because of said  controls,  which  resulted  in the
review,  discovery and disclosure by amendment of filings to adequately disclose
required information,  management also concludes that by requiring  supplemental
reviews of financing transactions that its existing controls and procedures will
be more effective.


Note E - Fair Value of Financial Instruments

The carrying amount of cash,  accounts  receivable,  accounts  payable and notes
payable, as applicable,  approximates fair value due to the short term nature of
these items  and/or the current  interest  rates  payable in relation to current
market conditions.

Interest  rate risk is the risk  that the  Company's  earnings  are  subject  to
fluctuations  in interest  rates on either  investments  or on debt and is fully
dependent  upon  the  volatility  of  these  rates.  The  Company  does  not use
derivative instruments to moderate its exposure to interest rate risk, if any.

Financial  risk  is  the  risk  that  the  Company's  earnings  are  subject  to
fluctuations in interest rates or foreign exchange rates and are fully dependent
upon the  volatility  of  these  rates.  The  company  does  not use  derivative
instruments to moderate its exposure to financial risk, if any.


Note F - Inventory

As of June 30, 2006, inventory, as valued using the lower-of-cost or market,
consisted of the following components:

                                          June 30,
                                            2006
                                        ----------
         Raw materials                  $  398,511
         Work in process                    19,313
         Finished goods                      8,852
                                        ----------
         Totals                         $  426,676
                                        ==========











                                       11




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note G - Property and Equipment

Property and equipment consist of the following components:

                                     June 30,         Estimated
                                       2006           useful life
                                    ------------- ---------------
   Manufacturing equipment          $   7,939,335     3-10 years
   Office furniture and fixtures           69,889     3- 7 years
   Leasehold improvements                 190,277     8-20 years
                                    -------------
                                        8,199,501
   Accumulated depreciation            (5,575,782)
   Impairment of recoverability
         of carrying value             (2,623,719)
                                    -------------
   Net property and equipment       $           -
                                    =============

Total depreciation expense charged to operations for the six month periods ended
June 30, 2006 and 2005, respectively, was approximately $31,024 and $409,880.

In  accordance  with  Statement  of  Financial  Accounting  Standards  No.  144,
"Accounting  for the Impairment or Disposal of Long-Lived  Assets",  the Company
follows the policy of  evaluating  all property  and  equipment as of the end of
each reporting  quarter.  At December 31, 2005,  pursuant to the requirements of
this  accounting  standard,  management  recorded an  impairment  for the future
recoverability of these assets of approximately $2,777,829.


Note H - Loans from Shareholders
                                                             June 30,   June 30,
                                                               2006      2005
                                                             ---------  --------
Notes payable to three  separate  shareholders.  Interest at
8.0%, payable monthly. Principal due at maturity on December
31, 2006.  Shareholder/lender  has the option to convert the
principal  amount  into  common  stock of the Company at the
lesser of 66-2/3% of the  average  closing bid and ask price
on the date of conversion  or $0.07 per share.  Each note is
unsecured.                                                   $1,075,000 $      -
                                                             ========== ========


Note I - Convertible Debenture

The Company  entered into a  Securities  Purchase  Agreement  with La Jolla Cove
Investors,  Inc. ("La Jolla") on October 4, 2002 for the sale of (I) $250,000 in
convertible  debentures and (ii) warrants to buy 30,000,000 shares of our common
stock.  On March 13, 2003 and May 6, 2003,  La Jolla  advanced an  aggregate  of
$350,000 to our company which such funding was  allocated  towards the principal
balance of our convertible debentures.







                                       12




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note I - Convertible Debenture - Continued

As of June 30, 2006, the  outstanding  balance on the  convertible  debenture is
approximately $226,365 and we have approximately 2,263,650 warrants outstanding.
A recap of the debenture activity is as follows:

                                            Debenture   Warrant
                                          (in dollars) (in shares)
                                          -------------------------
       Initial amount                     $  600,000      6,000,000
       2003 redemptions                     (208,635)    (2,086,350)
       2004 redemptions                     (125,000)    (1,250,000)
       2005 redemptions                      (40,000)      (400,000)
                                          ----------     ----------
       Balances outstanding
         at June 30, 2006                 $  226,365      2,263,650
                                          ==========     ==========

The  debentures  bear  interest at 8%,  mature on June 31 [sic],  2007,  and are
convertible  into the  Company's  common  stock,  at the  selling  stockholder's
option.  The  convertible  debentures  are  convertible  into the  number of the
Company's shares of common stock equal to the principal amount of the debentures
being  converted  multiplied  by 11,  less the product of the  conversion  price
multiplied by 10 times the dollar amount of the debenture.  The conversion price
for the  convertible  debentures  is the lesser of (I) $1.00 or (ii) seventy six
percent of the average of the five lowest volume weighted  average prices during
the twenty (20) trading days prior to the conversion.  Accordingly,  there is in
fact no limit on the number of shares into which the debenture may be converted.
However,  in the event that our market  price is less than $0.30 per share,  the
Company  will have the option to prepay the  debenture  at 125% rather than have
the debenture  converted.  In addition,  the selling stockholder is obligated to
exercise the warrant  concurrently with the submission of a conversion notice by
the selling  stockholder.  As of June 30, 2006, the warrant is exercisable  into
2,263,650 shares of common stock at an exercise price of $1.00 per share.

In December 2004, we entered into an addendum to the  convertible  debenture and
warrant whereby the Company agreed to the following:

     *    the discount multiplier was reduced from eighty percent to seventy six
          percent;
     *    within five  business  days after this  registration  statement  being
          declared  effective,  La  Jolla is  required  to  submit  a  debenture
          conversion  in the  amount of  $10,000  and every  ten  business  days
          thereafter La Jolla shall submit three additional debenture conversion
          in the amount of $10,000 each;
     *    within five  business  days after this  registration  statement  being
          declared effective, La Jolla shall wire $400,000 to us as a prepayment
          towards the exercise of its warrant; and
     *    immediately  following  the  sale of all  shares  held by La  Jolla in
          connection with the debenture  conversions in the aggregate  amount of
          $40,000,  La Jolla shall wire  $275,000 to us as a prepayment  towards
          the exercise of its warrant and shall submit a debenture conversion in
          the amount of $6,250 on the first business day of each month until the
          debenture is no longer outstanding.



                                       13



                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note I - Convertible Debenture - Continued

In May 2005, we entered into an additional addendum to the convertible debenture
and warrant whereby the Company agreed to the following:

     *    The Company shall deposit 4,000,000 unregistered shares in the name of
          LaJolla with the  Company's  Escrow Agent and,  upon  confirmation  of
          receipt,  LaJolla will wire the Company  $150,000 as an advance on the
          $400,000  amount that LaJolla was  obligated  to fund  pursuant to the
          December 2004 Addendum.  In the event that the Company's  Registration
          Statement  was not  declared  effective  within nine (9) months of the
          date of this Addendum, the 4,000,000 shares in escrow will be released
          to LaJolla and sold by LaJolla  pursuant to Rule 144. If LaJolla sells
          these  shares for net sales  proceeds of more than  $150,000  (without
          interest  accruing on this  amount),  the excess over $150,000 will be
          refunded to the Company.
     *    The  maturity  date  of the  convertible  debenture  and  warrant  was
          extended to June 31, [sic], 2007.
     *    All other terms and conditions remain in full force and effect.

LaJolla has contractually  agreed to restrict its ability to convert or exercise
its  warrants  and  receive  shares of our common  stock such that the number of
shares of common stock held by them and their  affiliates  after such conversion
or exercise does exceed 4.9% of the then issued and outstanding shares of common
stock.

Due to the  contractually  agreed  mandatory  conversion of this Debenture,  the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

As the warrant is  non-detachable  from the Debenture and requires  simultaneous
exercise upon  conversion of the Debenture,  no value was assigned to the issued
warrant.  Upon exercise of the warrant,  the Company will record the issuance of
the  underlying  shares as a new  issuance  of common  stock on the date of each
respective exercise.

On various dates through  December 31, 2003,  the  Debenture  Holder  elected to
convert an aggregate $208,635, through 24 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 4,561,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 2,086,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $2,086,350.

On various  dates between  January 1, 2004 and December 31, 2004,  the Debenture
Holder   elected  to  convert  an   aggregate   $125,000,   through  6  separate
transactions,  in outstanding  Debenture principal into registered common stock.



                                       14



                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note I - Convertible Debenture - Continued

This election  caused the Company to issue  4,150,000  shares of common stock to
the  Debenture  Holder.  Additionally,  pursuant  to  the  contract  terms,  the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase  1,250,000  shares of the Company's  common stock for gross proceeds of
$1,250,000.  As of December  31, 2004,  an aggregate of 1,000,000  shares of the
Company's  common  stock have been  issued by the  Company and are being held in
escrow by the Company's  counsel  pending receipt of the final $175,000 from the
Debenture Holder. As of June 30, 2006, this amount remains unpaid.

On various dates between June 28, 2005 and August 10, 2005, the Debenture Holder
elected to convert an aggregate  $40,000,  through 4 separate  transactions,  in
outstanding  Debenture  principal into  registered  common stock.  This election
caused the Company to issue  5,872,048  shares of common stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 400,000
shares of the Company's common stock for gross proceeds of $400,000.

Note J - Derivative Liability arising from Warrants

The Company  accounts  for debt with  embedded  conversion  features and warrant
issues in accordance with EITF 98-5: "Accounting for convertible securities with
beneficial  conversion features or contingency  adjustable  conversion" and EITF
No. 00-27:  "Application of issue No 98-5 to certain  convertible  instruments".
Conversion features determined to be beneficial to the holder are valued at fair
value and recorded to additional  paid in capital.  The Company  determines  the
fair value to be ascribed to the detachable warrants issued with the convertible
debentures  utilizing  the  Black-Scholes  method.  Any  discount  derived  from
determining the fair value to the debenture  conversion features and warrants is
amortized  to financing  cost over the life of the  debenture.  The  unamortized
discount, if any, upon the conversion of the debentures is expensed to financing
cost on a pro rata basis.

Debt issues with the variable  conversion features are considered to be embedded
derivatives  and are  accountable in accordance  with FASB 133;  "Accounting for
Derivative  Instruments and Hedging Activities".  The fair value of the embedded
derivative is recorded to derivative liability. This liability is required to be
marked each reporting period. The resulting discount on the debt is amortized to
interest expense over the life of the related debt.


Note K - Preferred Stock Transactions

Preferred  stock  consists  of the  following  as of June  30,  2006  and  2005,
respectively:

                                                       June 30, 2006
                                                     -------------------
                                                     # shares   value
                                                    --------- ----------
Series A Cumulative Convertible Preferred Stock        12,000 $   60,000
Series B Cumulative Convertible Preferred Stock        55,020    275,100
Series C Convertible Preferred Stock                1,905,882    324,000
Series E 8% Convertible Preferred Stock               100,000    500,000
                                                    --------- ----------
                                                    2,072,902 $1,159,100
                                                    ========= ==========









                                       15




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note K - Preferred Stock Transactions - Continued

Series A Convertible Preferred Stock

In September,  October and November 2001, the Company sold an aggregate  222,600
shares of $5.00 Series A Convertible  Preferred Stock (Series A Preferred Stock)
for total  proceeds  of  approximately  $1,113,000  through a Private  Placement
Memorandum.  The Series A Convertible  Preferred  Stock  provides for cumulative
dividends at a rate of 8.0% per year,  payable  quarterly,  in cash or shares of
the  Company's  common stock at the Company's  election.  Each share of Series A
Preferred  Stock is  convertible  into 11 shares of the  Company's  common stock
initially  at any time  after 6 months  of the  date of issue  and  prior to the
notice of redemption  at the option of the holder,  subject to  adjustments  for
customary  anti-dilution events. In December 2001, at the request of the holders
of the Series A Preferred Stock, the Company and the individual holders modified
the holding period for conversion to allow for conversion in December 2001.

In September 2001, the Company's principal stockholder  converted  approximately
$4,007,327 of unsecured  debt and  approximately  $3,546,273  of cumulative  and
unpaid accrued interest into 1,510,710 shares of Series A Preferred Stock.

In  September  2001, a creditor of the Company  agreed to convert  approximately
$10,000 of trade accounts payable into 2,000 shares of Series A Preferred Stock.

In December 2001,  concurrent with a modification in the holding period prior to
conversion,  certain holders of the Series A Preferred Stock orally notified the
Company of their intent to exercise the conversion  features on 1,749,720 issued
and outstanding  shares of Series A Preferred  Stock into  19,246,920  shares of
common  stock prior to December  31,  2001.  Due to the timing of the  requisite
documentation,  the  clerical  activities  related to this  conversion  were not
completed until February 2002.

In conjunction with the Series A Preferred Stock, certain shares were sold after
the Company's common stock was approved for trading by the National  Association
of Securities  Dealers on the OTC Bulletin  Board in October 2001. The shares of
Series A Preferred  Stock sold  subsequent  to this date had an  equivalent  per
share  value of  common  stock  below  the  ending  quoted  market  price of the
Company's common stock on their respective issue dates. This difference  created
a Beneficial  Conversion  Feature  Discount of  approximately  $1,207,993.  This
discount was then  amortized  over the unexpired time period between the date of
issue of the eligible shares and the eligible  conversion date, as amended.  All
of the shares sold  subsequent  to the initial  trading  date were  converted in
December  2001  and,  accordingly,  the  approximate  $1,207,993  in  Beneficial
Conversion Feature Discount was fully amortized to operations.

In December 2002, a holder of 5,000 shares of Series A Preferred Stock exercised
his  conversion  rights and converted  these shares of Series A Preferred  Stock
into 55,000 shares of restricted, unregistered common stock.

In January 2003,  three  separate  holders of 9,000 shares of Series A Preferred
Stock exercised their  conversion  rights and converted these shares of Series A
Preferred stock into 99,000 shares of restricted, unregistered common stock.



                                       16




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note K - Preferred Stock Transactions - Continued

Series B Convertible Preferred Stock

In May 2003,  the Company  sold an  aggregate  91,700  shares of $5.00  Series B
Convertible  Preferred  Stock (Series B Preferred  Stock) for total  proceeds of
approximately  $458,500 through a separate  Private  Placement  Memorandum.  The
Series B Convertible Preferred Stock provides for cumulative dividends at a rate
of 8.0% per year, payable  quarterly,  in cash or shares of the Company's common
stock at the  Company's  election.  Each  share of Series B  Preferred  Stock is
convertible  into 11 shares of the Company's  common stock initially at any time
after 6 months of the date of issue and prior to the notice of redemption at the
option of the holder, subject to adjustments for customary anti-dilution events.

In  September  and  December  2004,  respectively,  the  Holders of the Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340 shares of Series B Preferred Stock for 66,810  post-reverse  split shares
of restricted, unregistered common stock.

On March 31 and  June  30,  2006,  respectively,  the  holders  of the  Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340  shares  (9,170 shares per  conversion)  of Series B Preferred  Stock for
415,706 shares of restricted, unregistered common stock.

Series C Convertible Preferred Stock

In November  2004,  the Company sold  1,905,882  shares of Series C  Convertible
Preferred  Stock to an  existing  stockholder  and  officer of the  Company in a
private  transaction  pursuant to Section (4)2 of the Securities Act of 1933 for
gross proceeds of approximately $324,000. No underwriter was used in conjunction
with this transaction.

The Series C  Convertible  Preferred  Stock  provides for dividends at a rate of
4.0% per annum,  to be declared  and paid monthly in either cash or stock at the
discretion of the Company.

Each share of Series C  Preferred  Stock is  convertible  at a rate of $0.18 per
share into  1,800,000  shares of the  Company's  common stock at any time at the
option of the holder, subject to adjustments for customary anti-dilution events.

Series E 8% Convertible Preferred Stock

On March 1, 2006, the Company issued a Private Placement  Memorandum offering up
to 200,000  shares of 8%  Convertible  Preferred  Stock at an offering  price of
$5.00 per share on a "best efforts" basis through an unrelated placement agent.

The Series E 8% Convertible Preferred Stock provides for cumulative dividends at
the rate of 8% per  year,  payable  quarterly,  50% in cash and 50% in shares or
100% in cash at the Company's  election.  In the event the Company elects to pay
such dividends in shares of the Company's  Common Stock, the number of shares to
be issued shall be based on the average of the closing  prices of the  Company's
Common Stock, as reported on the NASDAQ Over the Counter Bulletin Board (or such
other  market on which the  Company's  Common  Stock is then  traded) for the 10
consecutive trading days preceding the record date for each such dividend,  with
such record date being the 14th day preceding the end of each calendar quarter.


                                       17



                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note K - Preferred Stock Transactions - Continued

Series E 8% Convertible Preferred Stock - continued

Each share of Series E Convertible  Preferred  Stock shall be  convertible  into
shares of the Company's Common Stock at any time after March 1, 2007. The number
of  shares to be issued  on a  conversion  shall be based on 80% of the  average
closing price of the Common Stock of the Company;  as reported on the NASDAQ OTC
Bulletin Board (or such other market on which such stock is traded) for ten (!0)
consecutive  trading days preceding the date the Company received notice of such
conversion.  Subject  to  certain  restrictions,  the  Series  E 8%  Convertible
Preferred Stock shall automatically  convert into shares of the Company's Common
Stock upon any of the  following  events:  (I) the sale by the Company of all or
substantially  all of  its  assets;  (ii)  the  consummation  of a  merger  or a
consolidation  in which the  Company is not the  survivor;  or (iii) the sale or
exchange of all or substantially all of the outstanding  shares of the Company's
common  stock  (including  by way of  merger,  consolidation,  or other  similar
action).

In the event of the liquidation,  dissolution or winding up of the Company,  the
holders  of  Series E  Convertible  Preferred  Stock  shall  have a  liquidation
preference  over  holders of common  stock and shares  junior to the Series E 8%
Convertible Preferred Stock equal to $5.50 per share. Additionally,  the Company
shall not impose or allow any additional  liens on it's existing fixed assets in
excess of  $1,000,000;  provided that at such time as total gross  proceeds from
the offering equal or exceed $2,000,000, the Company shall satisfy such existing
liens on its existing  fixed assets and shall not impose or allow any additional
liens on its existing  fixed assets unless  subordinated  to the interest of the
Series E 8%  Convertible  Preferred  Stock,  with such  preference  on the fixed
assets equal to the fixed asset value,  as  determined  in  accordance  with the
United States Generally Accepted Accounting  Principles ("GAAP"), of 150% of the
stated value of the aggregate of the outstanding  shares of Series E Convertible
Preferred  Stock  except for fixed  assets of the  Company  that were  otherwise
purchased pursuant to a security interest.

The Series E 8% Convertible  Preferred Stock shall be redeemable,  at the option
of the  Company,  for  cash in the  amount  of  $5.50  per  share  of  Series  E
Convertible  Preferred  Stock or for  shares of the  Company's  Common  Stock in
accordance with the Conversion  Rate, at any time after March 1, 2007, or in the
event the closing sale price of the Company's  Common Stock,  as reported on the
NASDAQ  Over the  Counter  Bulletin  Board  (or such  other  market on which the
Company's Common Stock is then traded),  is greater than or equal to $7.00 after
March 1, 2007 for any consecutive  five trading days. In addition,  the Series E
8% Convertible Preferred Stock shall be redeemable, at the option of the holder,
at any time for shares of the  Company's  Common  Stock in  accordance  with the
Conversion  Rate.  At any time after March 1, 2007, at the option of the holder,
the Series E 8% Convertible  Preferred Stock shall be redeemable for cash in the
amount of $5.10 per share of Series E Convertible  Preferred Stock or for shares
of the Company's Common Stock in accordance with the Conversion Rate. After such



                                       18




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note K - Preferred Stock Transactions - Continued

Series E 8% Convertible Preferred Stock - continued

date, if redemption is for cash,  shares will be redeemed at the rate of 1/10 of
such  aggregate  shares per  quarterly  period for any 10  consecutive  quarters
commencing  after  March 1, 2007.  Any  redemption  by either the Company or the
holder shall be subject to 15 days written notice.

The  Company  warrants  and  agrees  that if,  at any  time  within  the  period
commencing  on the date of the final closing of the Offering and expiring on the
5th  anniversary  of the date thereof,  the Company  should file a  registration
statement with the SEC under the Securities Act (other than in connection with a
merger or other  business  combination  transaction or pursuant to Form S-8), it
will give written  notice at least 30 calendar  days prior to the filing of each
such  registration  statement  to the  holders  of the  Series E 8%  Convertible
Preferred  Stock and the holders of the shares of the Common  Stock  issued upon
the  conversion or  redemption  of the shares of Series E Convertible  Preferred
Stock,  or their permitted  assigns  (Holders) of its intention to do so. If the
Holders  notify the Company  within 30 calendar  days after  receipt of any such
notice of its or their  desire to include any such shares of Common Stock issued
or issuable upon the  conversion  or  redemption of the Series E 8%  Convertible
Preferred Stock in such proposed registration  statement,  the Company shall use
its "best efforts" to have any such shares of Common Stock is issued or issuable
upon the conversion or redemption of the Series E 8% Convertible Preferred Stock
registered under such registration statement.

Notwithstanding  the  foregoing,  the  Company  shall have the right at any time
after it shall  have given  written  notice  (irrespective  of whether a written
request for inclusion of any such securities  shall have been made) to elect not
to file any such proposed registration  statement, or to withdraw the same after
the filing but prior to the effective date thereof. If the managing  underwriter
of an offering to which the above "piggyback registration rights" apply, in good
faith and for valid  business  reasons,  objects to such rights,  such objection
shall  preclude  such  inclusion.  All  expenses  incurred  by  the  Company  in
registration  of the  shares  of  Common  Stock  issued  or  issuable  upon  the
conversion  or  redemption  of The  Series  E 8%  Convertible  Preferred  Stock,
including with out limitation all  registration  and filing fees,  listing fees,
printing  expenses,  fees and  disbursements  of all  independent  accounts,  or
counsel for the Company  and the  expense of any special  audits  incident to or
required  by any  such  registration  and the  expenses  of  complying  with the
securities or blue sky laws of any jurisdiction shall be paid by the Company.

The Company has agreed to pay the Placement Agent a cash commission equal to 10%
of the aggregate Purchase Price of the shares of Series E Convertible  Preferred
Stock sold by the Placement  Agent in the Offering  (Placement  Agent Fee).  The
Company shall also pay the Placement Agent reasonable  expenses  associated with
the Offering,  which expenses shall not exceed $50,000 (Expense  Allowance).  In
addition,  the Company shall issue to the Placement  Agent 500 warrants for each
$50,000 of Series E Convertible  Preferred  Stock sold by the Placement Agent in
the Offering  (Placement Agent Warrants),  each warrant  entitling the holder to
purchase 1 share of the Company's Common Stock at an exercise price of $0.90 per
share exercisable at any time for a period of 3 years from date of issuance.

Upon completion of the Maximum  Offering,  the Company will receive net proceeds
of  approximately  $900,000.00.  The Company intends to use the net proceeds for
potential  acquisitions,   working  capital,   general  corporate  purposes  and
repayment of outstanding debt.



                                       19




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note K - Preferred Stock Transactions - Continued

Series E 8% Convertible Preferred Stock - continued

The  Company  and the  Placement  Agent shall have  discretion  to increase  the
Maximum Offering to $2,000,000.00, without notice to investors..

As of June 30,  2006,  the Company  has sold  100,000  shares in a two  separate
transactions under this Private Placement  Memorandum and has received the gross
sales proceeds of $500,000 and has paid an aggregate of $50,000 to the Placement
Agent for the 10% fees due on these transactions.


Note L - Common Stock Transactions

On January 9, 2006,  by written  consent in lieu of  meeting,  a majority of the
Company's  stockholders  approved a  recommendation  by the  Company's  Board of
Directors to effect a one share for twenty shares (1 for 20) reverse stock split
of our common stock, par value $.001 per share,  with fractional  shares rounded
up to the nearest whole share.  The reverse split became effective on that date.
As a result of the reverse  split,  the total  number of issued and  outstanding
shares  of  the   Company's   common  stock   decreased   from   92,576,839   to
4,629,381shares,  after giving  effect to rounding for  fractional  shares.  The
effect of this action is reflected in the Company's  financial  statements as of
the first day of the first period presented.

In  conjunction  with  the  above  discussed  reverse  stock  split,  all  share
references in the following paragraphs reflect the January 9, 2006 reverse split
action.

Calendar 2005 Transactions

On various dates between June 28, 2005 and August 10, 2005, the Debenture Holder
elected to convert an aggregate  $40,000,  through 4 separate  transactions,  in
outstanding  Debenture  principal into  registered  common stock.  This election
caused the  Company to issue  293,602  shares of common  stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 400,000
shares of the Company's common stock for gross proceeds of $400,000.

In  September  and  December  2004,  respectively,  the  Holders of the Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340  shares of Series B  Preferred  Stock for  66,810  shares of  restricted,
unregistered common stock.

In July 2005, the Company  issued  approximately  8,333 shares of  unregistered,
restricted  common  stock to Paul  Goebel,  the  Company's  Director of Domestic
Sales, as an employee bonus. These shares were valued at approximately  $17,166,
which  approximated the market value of the shares on the transaction  date. The
Company relied upon Section 4(2) of the Securities Act of 1933, as amended,  for
an exemption from  registration  of these shares and no underwriter  was used in
this transaction.




                                       20




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note L - Common Stock Transactions

Calendar 2005 Transactions - continued

In  February,  August,  September  and  December  2005,  the  Company  issued an
aggregate 23,615 shares of restricted,  unregistered  common stock in payment of
approximately  $44,124 in accrued dividends payable on the Company's outstanding
Series B Preferred  Stock for the quarters  ended  December 31, 2004,  March 31,
2005, June 30, 2005, September 30, 2005 and December 31, 2005, respectively. The
Company relied upon Section 4(2) of the Securities Act of 1933, as amended,  for
an exemption from  registration  of these shares and no underwriter  was used in
this transaction.

In August,  November  and December  2005,  respectfully,  the Company  issued an
aggregate 37,500 shares of restricted,  unregistered common stock to an existing
stockholder as payment of various fees and costs  associated with the funding of
approximately  $875,000  short-term  working  capital loans to the Company.  The
Company relied upon Section 4(2) of the Securities Act of 1933, as amended,  for
an exemption from  registration  of these shares and no underwriter  was used in
this transaction.

Calendar 2006 Transactions

In  February   2006,  the  Company   issued   approximately   41,666  shares  of
unregistered,  restricted common stock to Paul Goebel, the Company's Director of
Domestic Sales, as an employee bonus.  These shares were valued at approximately
$17,500,  which  approximated  the market value of the shares on the transaction
date.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

In February 2006, the Company issued approximately 226,065 shares of restricted,
unregistered  common  stock,  valued at  approximately  $18,325,  to an existing
stockholder as for payment of accrued  interest  associated  with  approximately
$875,000  short-term  working capital loans to the Company and  reimbursement of
direct public  relation  expenses.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this  transaction.  As the per share value
of this  transaction  was  substantially  less  than  the  "fair  value"  of the
Company's  common stock,  per the closing price of the Company's common stock on
the transaction date, the Company  recognized  "compensation  expense related to
the  issuance  of  common  stock at less  than  "fair  value"  in the  amount of
approximately $70,080 on this transaction.

In May 2006,  the Company  issued  approximately  266,511  shares of restricted,
unregistered  common  stock,  valued at  approximately  $21,054,  to an existing
stockholder as for payment of accrued  interest  associated  with  approximately
$975,000  short-term  working capital loans to the Company and  reimbursement of
direct public  relation  expenses.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this  transaction.  As the per share value
of this  transaction  was  substantially  less  than  the  "fair  value"  of the
Company's  common stock,  per the closing price of the Company's common stock on
the transaction date, the Company  recognized  "compensation  expense related to
the  issuance  of  common  stock at less  than  "fair  value"  in the  amount of
approximately $69,293 on this transaction.



                                       21




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note M - Rental Commitments

The Company  leases its  corporate  office and  manufacturing  facility from its
controlling  stockholder under a long-term operating lease agreement.  The lease
requires a monthly payment of approximately  $5,735,  including applicable sales
taxes.  The Company is responsible for all utilities and  maintenance  expenses.
The  lease  expires  on  December  1,  2009  and  contains  a clause  that  upon
expiration,  the Company and the controlling  stockholder  shall renegotiate the
annual rental amount.

The  Company's  subsidiary,  IPE,  leases it's  manufacturing  facility  from an
unrelated third-party under a long-term operating lease agreement. This lease is
for a period of five (5) years and requires graduated monthly payments, changing
on the lease anniversary date, ranging from approximately $1,751 to $1,914, plus
the applicable  sales taxes.  The Company is  responsible  for all utilities and
maintenance expenses.  The lease expires on February 28, 2007 and may be renewed
for an additional five (5) year term at a rental rate of  approximately  $1,971,
plus applicable sales taxes for the first renewal year and 3.0% increase on each
succeeding   anniversary   date.   Total  rent  expense  under  this  lease  was
approximately  $20,752 and  $16,622,  respectively,  for each of the years ended
December 31, 2004 and 2003.

In May  2004,  the  Company  entered  into a  long-term  lease  agreement  for a
warehouse  facility  adjacent to the Company's  primary office and manufacturing
facility.  This lease is for a period of two (2) years and requires  payments of
approximately  $6,206 per month for the first 12 months and approximately $6,393
for  the  second  12  months,  plus  applicable  sales  taxes.  The  Company  is
responsible  for all utilities and maintenance  expenses.  This lease expires on
May 31, 2006.  Further,  the Company is  responsible  for any  incremental  real
estate  taxes and property  insurance  in excess of the amounts  incurred by the
landlord for the calendar year immediately preceding the execution of the lease.

Future minimum rental payments on the above leases are as follows:

                    Year ended
                    December 31,         Amount

                    2006               $ 117,244
                    2007                  72,643
                    2008                  68,815
                    2007                  68,815
                                       ---------
                    Totals             $ 327,517
                                       =========

For the respective years ended December 31, 2005 and 2004, the Company paid an
aggregate of $158,947 and $131,804 in rent under these three lease agreements.






                [Balance of this page intentionally left blank.]









                                       22




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note N - Income Taxes

The  components of income tax (benefit)  expense for the six month periods ended
June 30, 2006 and 2005, respectively, are as follows:

                               Six months        Six months
                                  ended             ended
                                June 30,          June 30,
                                  2006            2005
                               -----------------------------
       Federal:
         Current                $     -           $    -
         Deferred                     -                -
                                -------           ------
                                      -                -
                                -------           ------
       State:
         Current                      -                -
         Deferred                     -                -
                                -------           ------
                                      -                -
                                -------           ------
         Total                  $     -           $    -
                                =======           ======

As of December 31, 2005,  the Company has a net operating loss  carryforward  of
approximately  $12,000,000 to offset future taxable  income.  Subject to current
regulations, components of this carryforward began to expire in 2005. The amount
and  availability  of the net  operating  loss  carryforwards  may be subject to
limitations set forth by the Internal  Revenue Code.  Factors such as the number
of shares ultimately issued within a three year look-back period;  whether there
is a deemed more than 50 percent change in control; the applicable long-term tax
exempt bond rate;  continuity of historical  business;  and subsequent income of
the  Company  all  enter  into  the  annual   computation  of  allowable  annual
utilization of the carryforwards.

The Company's income tax expense  (benefit) for the six month periods ended June
30, 2006 and 2005, respectively,  differed from the statutory federal rate of 34
percent as follows:

                                                          Six months  Six months
                                                             ended       ended
                                                           June 30,    June 30,
                                                             2006      2005
                                                          ----------------------

Statutory rate applied to loss before income taxes        $(512,000)  $(683,000)
Increase (decrease) in income taxes resulting from:
     State income taxes                                           -           -
     Other, including reserve for deferred tax asset        512,000     683,000
                                                          ---------   ---------
       Income tax expense                                 $       -   $       -
                                                          =========   =========



                                       23




                   American Ammunition, Inc. and Subsidiaries
         Notes to Restated Consolidated Financial Statements - Continued
                             June 30, 2006 and 2005


Note N - Income Taxes - continued

Temporary differences, consisting primarily of the net operating loss
carryforward and statutory differences in the depreciable lives for property and
equipment, between the financial statement carrying amounts and tax bases of
assets and liabilities give rise to deferred tax assets and liabilities as of
December 31, 2005 and 2004, respectively:

                                                    Year ended     Year ended
                                                   December 31,   December 31,
                                                       2005            2004
                                                   -----------------------------
     Deferred tax assets - long-term
       Net operating loss carryforwards            $ 4,080,000      $ 2,669,000
     Deferred tax liabilities - long-term
       Statutory depreciation differences             (525,000)        (690,000)
                                                   -----------      -----------
                                                     3,555,000        1,979,000
     Less valuation allowance                       (3,555,000)      (1,979,000)
                                                   -----------      -----------
       Net Deferred Tax Asset                      $         -      $         -
                                                   ===========      ===========

During the years ended December 31, 2005 and 2004,  respectively,  the valuation
allowance increased (decreased) by approximately $1,576,000 and $(671,000).





                [Balance of this page intentionally left blank.]










                                       24




ITEM 2 - Management's Discussion and Analysis or Plan of Operation

Caution Regarding Forward-Looking Information

     Certain  statements  contained in this  Registration  Statement  including,
without limitation,  statements containing the words "believes",  "anticipates",
"expects" and words of similar import,  constitute  forward-looking  statements.
Such forward-looking  statements involve known and unknown risks,  uncertainties
and other factors that may cause the actual results, performance or achievements
of the Company, or industry results, to be materially  different from any future
results,   performance   or   achievements   expressed   or   implied   by  such
forward-looking statements.

     Such factors include, among others, the following: international,  national
and local  general  economic and market  conditions:  demographic  changes;  the
ability of the Company to sustain, manage or forecast its growth; the ability of
the Company to successfully make and integrate acquisitions;  raw material costs
and availability; new product development and introduction;  existing government
regulations  and  changes  in,  or  the  failure  to  comply  with,   government
regulations;  adverse publicity;  competition; the loss of significant customers
or suppliers;  fluctuations  and  difficulty in forecasting  operating  results;
changes in business strategy or development  plans;  business  disruptions;  the
ability  to attract  and  retain  qualified  personnel;  the  ability to protect
technology; and other factors referenced in this and previous filings.

     Given  these  uncertainties,  readers  of  this  Quarterly  Report  on Form
10-QSB/A and investors in our equity securities are cautioned not to place undue
reliance  on  such  forward-looking   statements.   The  Company  disclaims  any
obligation to update any such factors or to publicly  announce the result of any
revisions to any of the forward-looking  statements  contained herein to reflect
future events or developments.

Restatement issues

     The June 30,  2006 and 2005  financial  statements  have been  restated  to
account for the derivative  liability  that was incurred in connection  with the
common stock  conversion  features and the  warrants  issued with certain  notes
payable  (see  Notes  I  and  J  to  the  accompanying   consolidated  financial
statements).

     The Company accounts for debt with embedded conversion features and warrant
issues in accordance with EITF 98-5: "Accounting for convertible securities with
beneficial  conversion features or contingency  adjustable  conversion" and EITF
No. 00-27:  "Application of issue No 98-5 to certain  convertible  instruments".
Conversion features determined to be beneficial to the holder are valued at fair
value and recorded to additional  paid in capital.  The Company  determines  the
fair value to be ascribed to the detachable warrants issued with the convertible
debentures  utilizing  the  Black-Scholes  method.  Any  discount  derived  from
determining the fair value to the debenture  conversion features and warrants is
amortized  to financing  cost over the life of the  debenture.  The  unamortized
discount, if any, upon the conversion of the debentures is expensed to financing
cost on a pro rata basis.

     Debt issues with the  variable  conversion  features are  considered  to be
embedded   derivatives   and  are  accountable  in  accordance  with  FASB  133;
"Accounting for Derivative  Instruments and Hedging Activities".  The fair value
of the embedded derivative is recorded to derivative  liability.  This liability
is required to be marked each reporting  period.  The resulting  discount on the
debt is amortized to interest expense over the life of the related debt.

General

     American  Ammunition,   Inc.  is  a  holding  company  with  two  operating
subsidiaries: F&F Equipment, Inc. and Industrial Plating Enterprise Co.



                                       25




     F&F  Equipment,  Inc. (F&F) was  incorporated  on October 4, 1983 under the
laws of the  State of  Florida.  F&F was  formed to  engage  principally  in the
"import,  export,  retail & wholesale of firearms equipment,  ammunition & other
devices and for the purpose of transacting any and/or all lawful  business." F&F
conducts   its  business   operations   under  the  assumed  name  of  "American
Ammunition."

     In June 2002, American  Ammunition,  Inc. formed a wholly owned subsidiary,
Industrial  Plating  Enterprise Co. (IPE),  which started production on June 14,
2002.  IPE  is a  fully  licensed  and  approved  electrochemical  metallization
facility with  significant  capacity for  processing  our line of projectiles as
well as other products and services while employing  environmentally sound water
conservation and proven waste treatment techniques.

Results of Operations

Six months ended June 30, 2006 compared with the six months ended June 30, 2005.

     During the six months ended June 30, 2006,  we  experienced  aggregate  net
revenues of  approximately  $1,379,000  ($669,000  in the current  quarter),  as
compared  to  approximately  $1,855,000  during the first six months of Calendar
2005.  The decline in sales was  attributable  to our  curtailing  of production
during  January 2006 to improve the operating  efficiency  of our  manufacturing
equipment and better  automate  select  machines so we can rely upon lower labor
requirements in future periods.

     In 2004,  the  Company  initiated  a direct  solicitation  program for it's
"dealer  direct"  sales  program.  This  endeavor has  received a very  positive
initial response from the qualified  retail resellers of the Company's  product.
We are  realizing  that the  existence of previously  announced  contracts  with
various U. S.  Governmental  agencies  and orders from foreign  governments  are
becoming  more erratic in their order  placements.  Accordingly,  management  is
realizing  that a  consistent  demand from the U. S. retail  segment will be our
best source of consistent sales.  Further, we have identified certain production
issues which has inhibited the full  realization of existing product demands and
management  believes  that the  necessary  steps are being  taken to remedy  any
production deficiencies.

     We experienced costs of goods sold of approximately  $2,043,000 for the six
months ended June 30, 2006 as compared to approximately $2,885,000 for the first
six months of Calendar 2005. Through June 30, 2006, and subsequent  thereto,  we
continue to experience  negative trends with relation to our calculated standard
production  costs for  material  and labor due to excess  labor  capacity due to
anticipated  governmental orders which did not materialize as management was led
to believe from the various U. S. Governmental  agencies  contracting  officers.
Management  remains of the opinion that the production labor force is stable and
able to maintain a constant standard of quality in future periods. We experience
variable  costs in the area of material  consumption  and direct  labor.  In the
second  quarter of 2006,  management  took drastic  steps to reduce excess labor
capacity through the elimination of the 2nd shift, which was never able to reach
full utilization.  This action is not expected to have any adverse impact on our
ability to meet our existing and future product demands.

     For the six month  periods  ended June 30,  2006 and 2005,  we  generated a
(negative)  gross  profit  of  approximately   $(664,000),   or  (48.11%),   and
approximately $(1,030,000), or (55.53%).

     We experienced  nominal research and development  expenses of approximately
$-0- and $1,600,  respectively,  during the  respective  six month periods ended
June 30, 2006 and 2005.

     During the six months of Calendar 2006 and 2005, we expended  approximately
$74,000 and $112,000,  respectively,  in  advertising  and  marketing  expenses,
principally  in developing  and promoting our retail dealer direct  program.  We



                                       26




anticipate  to continue our  marketing  efforts in this area in future  periods;
however,  the  volume  and  frequency  of  our  expenditures  may  fluctuate  as
management allocates available capital to these efforts.

     Other  general  and  administrative   expenses  increased   nominally  from
approximately  $663,000  for the six months  ended June 30,  2006 as compared to
approximately  $631,000 for the six months ended June 30, 2005. Management is of
the opinion  that these costs are  relatively  stable and should not  experience
significant  increases except for inflationary  pressures caused  principally by
increases in energy costs which are affecting  all  businesses in all sectors of
the U. S. economy.  We also  incurred  non-cash  charges to  operations  for the
difference between the selling price of our common stock on certain transactions
during both Calendar 2006 and 2005 and the fair value of the securities  sold as
determined  by the quoted  closing  price of our common  stock on the date(s) of
each respective transaction.  Through June 30, 2006 and 2005,  respectively,  we
charged approximately $139,000 and $201,000 to operations for this differential.

     We recognized a net loss of approximately $(1,731,000) and $(2,014,000) for
the respective six month periods ended June 30, 2006 and 2005, respectively,  or
$(0.39) and $(0.59) per share.  We call to the reader's  attention that the loss
per share  calculation  for the six months ended June 30, 2006 and 2005 includes
the effect of our 1 for 20 reverse stock split on January 9, 2006.

Liquidity And Capital Resources

     As of June 30, 2006, December 31, 2005 and June 30, 2005, respectively,  we
had working capital of  approximately  $(4,962,000),  $(885,000) and $(265,000).
Our working capital position  continues to fluctuate based on collections on our
trade accounts  receivable and  investments  from the mandatory  exercise of our
outstanding warrant related to our convertible debenture.  We anticipate that we
have sufficient  inventory levels to support our order demand and have access to
raw material  suppliers  that will enable us to receive raw materials for future
periods. We also note that we have approximately  $1,075,000 in short-term notes
payable to existing stockholders which may or may not be renegotiated, repaid in
common stock of the Company or otherwise reclassified prior to their maturity on
December 31, 2006. This amount is a contributing  factor to our negative working
capital position at June 30, 2006 and December 31, 2005.

     We have used cash in operating  activities of approximately  $(750,000) and
$(797,000)  during  the  six  month  periods  ended  June  30,  2006  and  2005,
respectively.  Due to  our  history  of  operating  losses,  our  resources  for
additional working capital are becoming more scarce. Additionally,  LaJolla Cove
Investors,  the holder of our  mandatorily  convertible  debenture  and  related
warrant,  is in default on their agreement to provide us with additional working
capital.  On March 1, 2006,  the Company issued a Private  Placement  Memorandum
offering up to 200,000 shares of 8% Convertible  Preferred  Stock at an offering
price  of $5.00  per  share  on a "best  efforts"  basis  through  an  unrelated
placement  agent.  As of June 30,  2006,  the Company has sold an  aggregate  of
100,000  shares for gross  proceeds  of $500,000  in two  separate  transactions
pursuant to this Private Placement Memorandum. Management continues to undertake
all prudent measures to assure that the Company can be self-supporting.

     We  anticipate  that our  liquidity  position  will  continue to improve as
management is of the opinion that,  with the current  changes to our  production
capacity,  the  Company  will be in a position to better  support  all  existing
orders and accept existing and future inquiries.

     During the six months ended June 30, 2006 and 2005, respectively,  we added
approximately $31,000 and $98,000 in new equipment. Any equipment to be added in
future  periods  is  fully  dependent  upon the  Company's  cash  position,  the



                                       27




availability  of either new equity or debt capital and the ultimate  realization
of  communicated  future  product sales demand.  However,  we may not be able to
obtain additional funding or, that such funding, if available,  will be obtained
on terms favorable to or affordable by us.

Convertible Debenture

     The Company entered into a Securities Purchase Agreement with La Jolla Cove
Investors,  Inc. ("La Jolla") on October 4, 2002 for the sale of (I) $250,000 in
convertible  debentures and (ii) warrants to buy 30,000,000 shares of our common
stock.  On March 13, 2003 and May 6, 2003,  La Jolla  advanced an  aggregate  of
$350,000 to our company which such funding was  allocated  towards the principal
balance of our convertible debentures.

     As of June 30, 2006, the outstanding  balance on the convertible  debenture
is  approximately   $226,365  and  we  have  approximately   2,263,650  warrants
outstanding. A recap of the debenture activity is as follows:

                                            Debenture   Warrant
                                          (in dollars) (in shares)
                                          -------------------------
       Initial amount                     $  600,000      6,000,000
       2003 redemptions                     (208,635)    (2,086,350)
       2004 redemptions                     (125,000)    (1,250,000)
       2005 redemptions                      (40,000)      (400,000)
                                          ----------     ----------
       Balances outstanding
         at June 30, 2006                 $  226,365      2,263,650
                                          ==========     ==========

     The debentures bear interest at 8%, mature on June 31 [sic],  2007, and are
convertible  into the  Company's  common  stock,  at the  selling  stockholder's
option.  The  convertible  debentures  are  convertible  into the  number of the
Company's shares of common stock equal to the principal amount of the debentures
being  converted  multiplied  by 11,  less the product of the  conversion  price
multiplied by 10 times the dollar amount of the debenture.  The conversion price
for the  convertible  debentures  is the lesser of (I) $1.00 or (ii) seventy six
percent of the average of the five lowest volume weighted  average prices during
the twenty (20) trading days prior to the conversion.  Accordingly,  there is in
fact no limit on the number of shares into which the debenture may be converted.
However,  in the event that our market  price is less than $0.30 per share,  the
Company  will have the option to prepay the  debenture  at 125% rather than have
the debenture  converted.  In addition,  the selling stockholder is obligated to
exercise the warrant  concurrently with the submission of a conversion notice by
the selling  stockholder.  As of June 30, 2006, the warrant is exercisable  into
2,263,650 shares of common stock at an exercise price of $1.00 per share.

     In December 2004, we entered into an addendum to the convertible  debenture
and warrant whereby the Company agreed to the following:

     *    the discount multiplier was reduced from eighty percent to seventy six
          percent;
     *    within five  business  days after this  registration  statement  being
          declared  effective,  La  Jolla is  required  to  submit  a  debenture
          conversion  in the  amount of  $10,000  and every  ten  business  days
          thereafter La Jolla shall submit three additional debenture conversion
          in the amount of $10,000 each;
     *    within five  business  days after this  registration  statement  being
          declared effective, La Jolla shall wire $400,000 to us as a prepayment
          towards the exercise of its warrant; and
     *    immediately  following  the  sale of all  shares  held by La  Jolla in
          connection with the debenture  conversions in the aggregate  amount of
          $40,000,  La Jolla shall wire  $275,000 to us as a prepayment  towards
          the exercise of its warrant and shall submit a debenture conversion in
          the amount of $6,250 on the first business day of each month until the
          debenture is no longer outstanding.



                                       28




     In May 2005,  we entered  into an  additional  addendum to the  convertible
debenture and warrant whereby the Company agreed to the following:

     *    The Company shall deposit 4,000,000 unregistered shares in the name of
          LaJolla with the  Company's  Escrow Agent and,  upon  confirmation  of
          receipt,  LaJolla will wire the Company  $150,000 as an advance on the
          $400,000  amount that LaJolla was  obligated  to fund  pursuant to the
          December 2004 Addendum.  In the event that the Company's  Registration
          Statement  was not  declared  effective  within nine (9) months of the
          date of this Addendum, the 4,000,000 shares in escrow will be released
          to LaJolla and sold by LaJolla  pursuant to Rule 144. If LaJolla sells
          these  shares for net sales  proceeds of more than  $150,000  (without
          interest  accruing on this  amount),  the excess over $150,000 will be
          refunded to the Company.
     *    The  maturity  date  of the  convertible  debenture  and  warrant  was
          extended to June 31, [sic], 2007.
     *    All other terms and conditions remain in full force and effect.

     LaJolla  has  contractually  agreed to  restrict  its ability to convert or
exercise  its  warrants  and  receive  shares of our common  stock such that the
number of shares of common  stock held by them and their  affiliates  after such
conversion  or exercise  does  exceed  4.9% of the then  issued and  outstanding
shares of common stock.

     Due to the contractually agreed mandatory conversion of this Debenture, the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

     As  the  warrant  is   non-detachable   from  the  Debenture  and  requires
simultaneous exercise upon conversion of the Debenture, no value was assigned to
the issued  warrant.  Upon exercise of the warrant,  the Company will record the
issuance of the underlying  shares as a new issuance of common stock on the date
of each respective exercise.

     On various dates through December 31, 2003, the Debenture Holder elected to
convert an aggregate $208,635, through 24 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 4,561,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 2,086,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $2,086,350.

     On  various  dates  between  January 1, 2004 and  December  31,  2004,  the
Debenture  Holder elected to convert an aggregate  $125,000,  through 6 separate
transactions,  in outstanding  Debenture principal into registered common stock.
This election  caused the Company to issue  4,150,000  shares of common stock to
the  Debenture  Holder.  Additionally,  pursuant  to  the  contract  terms,  the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase  1,250,000  shares of the Company's  common stock for gross proceeds of
$1,250,000.  As of December  31, 2004,  an aggregate of 1,000,000  shares of the
Company's  common  stock have been  issued by the  Company and are being held in
escrow by the Company's  counsel  pending receipt of the final $175,000 from the
Debenture Holder. As of June 30, 2006, this amount remains unpaid.



                                       29




     On various dates  between June 28, 2005 and August 10, 2005,  the Debenture
Holder elected to convert an aggregate $40,000, through 4 separate transactions,
in outstanding  Debenture  principal into registered common stock. This election
caused the Company to issue  5,872,048  shares of common stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 400,000
shares of the Company's common stock for gross proceeds of $400,000.

     LaJolla  is in  default  on their  contractual  agreements  to  redeem  the
outstanding  warrant(s)  and convert the  outstanding  debenture  as of June 30,
2006.


ITEM 3 - Controls and Procedures

(a)  Evaluation of Disclosure Controls and Procedures

     Under  the  supervision  and  with  the  participation  of our  management,
including our principal  executive officer and principal  financial officer,  we
conducted an evaluation of our disclosure controls and procedures,  as such term
is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of
1934, as amended  (Exchange Act), for the quarter ended June 30, 2006. As of the
end of the  period  covered  by this  report,  management,  including  the chief
executive officer and chief financial officer evaluated the effectiveness of the
design and operation of our disclosure  controls and procedures.  Based upon and
as of the date of that evaluation, our CEO and CFO concluded that the disclosure
controls and procedures were effective

(b)  Changes in Internal Controls

     There were no significant changes (including corrective actions with regard
to significant  deficiencies  or material  weaknesses) in our internal  controls
over financial  reporting  that occurred  during the quarter ended June 30, 2006
that has materially affected,  or is reasonably likely to materially affect, our
internal control over financial reporting.



                           PART II - OTHER INFORMATION


ITEM 1 - Legal Proceedings

     The Company may become involved in various claims and legal actions arising
in the ordinary course of business.  In the opinion of management,  the ultimate
disposition  of these  matters will not have a material  adverse  impact  either
individually  or  in  the  aggregate  on  consolidated  results  of  operations,
financial position or cash flows of the Company.


ITEM 2 - Unregistered Sales of Equity Securities and Use of Proceeds

     On March 31 and June 30,  2006,  respectively,  the holders of the Series B
Preferred  Stock exercised  their  conversion  rights and exchanged an aggregate
18,340  shares  (9,170 shares per  conversion)  of Series B Preferred  Stock for
415,706 shares of restricted, unregistered common stock.

     In May 2006, the Company issued approximately 266,511 shares of restricted,
unregistered  common  stock,  valued at  approximately  $21,054,  to an existing
stockholder as for payment of accrued  interest  associated  with  approximately
$975,000  short-term  working capital loans to the Company and  reimbursement of
direct public  relation  expenses.  The Company  relied upon Section 4(2) of the



                                       30




Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this  transaction.  As the per share value
of this  transaction  was  substantially  less  than  the  "fair  value"  of the
Company's  common stock,  per the closing price of the Company's common stock on
the transaction date, the Company  recognized  "compensation  expense related to
the  issuance  of  common  stock at less  than  "fair  value"  in the  amount of
approximately $69,293 on this transaction

   Series E 8% Convertible Preferred Stock

     On  March 1,  2006,  the  Company  issued a  Private  Placement  Memorandum
offering up to 200,000 shares of 8% Convertible  Preferred  Stock at an offering
price  of $5.00  per  share  on a "best  efforts"  basis  through  an  unrelated
placement agent.

     The  Series  E 8%  Convertible  Preferred  Stock  provides  for  cumulative
dividends at the rate of 8% per year, payable quarterly,  50% in cash and 50% in
shares or 100% in cash at the  Company's  election.  In the  event  the  Company
elects to pay such dividends in shares of the Company's Common Stock, the number
of shares to be issued  shall be based on the average of the  closing  prices of
the Company's  Common Stock, as reported on the NASDAQ Over the Counter Bulletin
Board (or such other market on which the Company's  Common Stock is then traded)
for the 10  consecutive  trading  days  preceding  the record date for each such
dividend,  with such  record date being the 14th day  preceding  the end of each
calendar quarter.

     Each share of Series E  Convertible  Preferred  Stock shall be  convertible
into shares of the Company's  Common Stock at any time after March 1, 2007.  The
number  of shares  to be  issued  on a  conversion  shall be based on 80% of the
average  closing  price of the Common Stock of the  Company;  as reported on the
NASDAQ OTC  Bulletin  Board (or such other market on which such stock is traded)
for ten (!0)  consecutive  trading days preceding the date the Company  received
notice of such  conversion.  Subject  to certain  restrictions,  the Series E 8%
Convertible  Preferred  Stock  shall  automatically  convert  into shares of the
Company's  Common Stock upon any of the  following  events:  (I) the sale by the
Company of all or  substantially  all of its assets;  (ii) the consummation of a
merger or a consolidation in which the Company is not the survivor; or (iii) the
sale or exchange of all or  substantially  all of the outstanding  shares of the
Company's  common stock  (including  by way of merger,  consolidation,  or other
similar action).

     In the event of the liquidation,  dissolution or winding up of the Company,
the holders of Series E  Convertible  Preferred  Stock shall have a  liquidation
preference  over  holders of common  stock and shares  junior to the Series E 8%
Convertible Preferred Stock equal to $5.50 per share. Additionally,  the Company
shall not impose or allow any additional  liens on it's existing fixed assets in
excess of  $1,000,000;  provided that at such time as total gross  proceeds from
the offering equal or exceed $2,000,000, the Company shall satisfy such existing
liens on its existing  fixed assets and shall not impose or allow any additional
liens on its existing  fixed assets unless  subordinated  to the interest of the
Series E 8%  Convertible  Preferred  Stock,  with such  preference  on the fixed
assets equal to the fixed asset value,  as  determined  in  accordance  with the
United States Generally Accepted Accounting  Principles ("GAAP"), of 150% of the
stated value of the aggregate of the outstanding  shares of Series E Convertible
Preferred  Stock  except for fixed  assets of the  Company  that were  otherwise
purchased pursuant to a security interest.

     The Series E 8% Convertible  Preferred  Stock shall be  redeemable,  at the
option  of the  Company,  for cash in the  amount of $5.50 per share of Series E
Convertible  Preferred  Stock or for  shares of the  Company's  Common  Stock in
accordance with the Conversion  Rate, at any time after March 1, 2007, or in the
event the closing sale price of the Company's  Common Stock,  as reported on the



                                       31




NASDAQ  Over the  Counter  Bulletin  Board  (or such  other  market on which the
Company's Common Stock is then traded),  is greater than or equal to $7.00 after
March 1, 2007 for any consecutive  five trading days. In addition,  the Series E
8% Convertible Preferred Stock shall be redeemable, at the option of the holder,
at any time for shares of the  Company's  Common  Stock in  accordance  with the
Conversion  Rate.  At any time after March 1, 2007, at the option of the holder,
the Series E 8% Convertible  Preferred Stock shall be redeemable for cash in the
amount of $5.10 per share of Series E Convertible  Preferred Stock or for shares
of the Company's Common Stock in accordance with the Conversion Rate. After such
date, if redemption is for cash,  shares will be redeemed at the rate of 1/10 of
such  aggregate  shares per  quarterly  period for any 10  consecutive  quarters
commencing  after  March 1, 2007.  Any  redemption  by either the Company or the
holder shall be subject to 15 days written notice.

     The  Company  warrants  and agrees  that if, at any time  within the period
commencing  on the date of the final closing of the Offering and expiring on the
5th  anniversary  of the date thereof,  the Company  should file a  registration
statement with the SEC under the Securities Act (other than in connection with a
merger or other  business  combination  transaction or pursuant to Form S-8), it
will give written  notice at least 30 calendar  days prior to the filing of each
such  registration  statement  to the  holders  of the  Series E 8%  Convertible
Preferred  Stock and the holders of the shares of the Common  Stock  issued upon
the  conversion or  redemption  of the shares of Series E Convertible  Preferred
Stock,  or their permitted  assigns  (Holders) of its intention to do so. If the
Holders  notify the Company  within 30 calendar  days after  receipt of any such
notice of its or their  desire to include any such shares of Common Stock issued
or issuable upon the  conversion  or  redemption of the Series E 8%  Convertible
Preferred Stock in such proposed registration  statement,  the Company shall use
its "best efforts" to have any such shares of Common Stock is issued or issuable
upon the conversion or redemption of the Series E 8% Convertible Preferred Stock
registered under such registration statement. Notwithstanding the foregoing, the
Company  shall  have the right at any time  after it shall  have  given  written
notice  (irrespective  of whether a written  request for  inclusion  of any such
securities  shall  have  been  made)  to elect  not to file  any  such  proposed
registration  statement,  or to withdraw  the same after the filing but prior to
the effective date thereof. If the managing  underwriter of an offering to which
the above  "piggyback  registration  rights" apply,  in good faith and for valid
business  reasons,  objects to such rights,  such objection  shall preclude such
inclusion. All expenses incurred by the Company in registration of the shares of
Common Stock issued or issuable upon the  conversion or redemption of The Series
E 8% Convertible Preferred Stock, including with out limitation all registration
and filing fees, listing fees, printing expenses,  fees and disbursements of all
independent  accounts, or counsel for the Company and the expense of any special
audits  incident  to or required by any such  registration  and the  expenses of
complying with the securities or blue sky laws of any jurisdiction shall be paid
by the Company.

     The Company has agreed to pay the Placement Agent a cash  commission  equal
to 10% of the  aggregate  Purchase  Price of the shares of Series E  Convertible
Preferred  Stock sold by the Placement  Agent in the Offering  (Placement  Agent
Fee).  The  Company  shall  also pay the  Placement  Agent  reasonable  expenses
associated with the Offering,  which expenses shall not exceed $50,000  (Expense
Allowance).  In addition,  the Company  shall issue to the  Placement  Agent 500
warrants for each $50,000 of Series E  Convertible  Preferred  Stock sold by the
Placement  Agent  in the  Offering  (Placement  Agent  Warrants),  each  warrant
entitling  the holder to purchase 1 share of the  Company's  Common  Stock at an
exercise  price of $0.90  per  share  exercisable  at any time for a period of 3
years from date of issuance.

     Upon  completion  of the Maximum  Offering,  the Company  will  receive net
proceeds  of  approximately  $900,000.00.  The  Company  intends  to use the net
proceeds for potential acquisitions, working capital, general corporate purposes
and repayment of outstanding debt.



                                       32




     The Company and the Placement  Agent shall have  discretion to increase the
Maximum Offering to $2,000,000.00, without notice to investors..


ITEM 3 - Defaults on Senior Securities

     None


ITEM 4 - Submission of Matters to a Vote of Security Holders

     None


ITEM 5 - Other Information

     None


ITEM 6 - Exhibits and Reports on Form 8-K

     (a) The following  sets forth those  exhibits filed pursuant to Item 601 of
Regulation S-K:

Exhibit     Descriptions
--------  -----------------------
31.1      Certification pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
32.1      Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002.

     (b) The following  sets forth the  Company's  reports on Form 8-K that have
been filed during the quarter for which this report is filed:

     None.




                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                            American Ammunition, Inc.


Dated: October 19,2007         /s/ Andres F. Fernandez
      -------------------      -----------------------------------------
                               Andres F. Fernandez
                               President, Chief Executive Officer
                               Chief Financial Officer and Director





                                       33